AK

Ajay Kumar Tiwari

Active Director Director DIN 08306335
DIN 08306335 First appointment Dec 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Ajay Kumar Tiwari

Data last updated:

Ajay Kumar Tiwari is a Director at Tiwari Pharma Private Limited (since 2018). The company operates in Pharma. Tiwari Pharma Private Limited reported revenue of ₹561 Cr (FY 2024).

DIN 08306335
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2018
Oldest Company Age 7 yrs
Largest company Tiwari Pharma Private Limited · ₹561 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tiwari Pharma Private Limited U24304HP2018PTC007271
Director17 Dec 20182018₹561 Cr (FY 2024)Active

Board colleagues of Ajay Kumar Tiwari

Directorship timeline

Open interactive timeline →
Tiwari Pharma Private Limited
Premium access

Shareholding and investment profile for Ajay Kumar Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Kumar Tiwari

Ajay Kumar Tiwari currently holds 1 directorship: Tiwari Pharma Private Limited (Director, since 17 Dec 2018, revenue ₹561 Cr (FY 2024)).

Ajay Kumar Tiwari was first appointed on 17 Dec 2018 as Director at Tiwari Pharma Private Limited.

The current boards of Ajay Kumar Tiwari's companies include Dhirendra Kumar Tiwari (Tiwari Pharma Private Limited), Dilip Kumar Tiwari (Tiwari Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available